Rupperswil, Switzerland

Stefan Lander

This inventor holds 1 USPTO granted patent and 4 published patent applications and 3 EPO patents. Top assignee: Omya International Ag. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Lander

Introduction

Stefan Lander is a notable inventor based in Rupperswil, Switzerland. He has made significant contributions to the field of pharmaceuticals and nutraceuticals. His work focuses on developing high-performance excipients that enhance the effectiveness of various compositions.

Latest Patents

Stefan Lander holds a patent for a "High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate." This invention refers to a particulate pharmaceutical or nutraceutical excipient, a process for its preparation, and a pharmaceutical or nutraceutical composition that includes this excipient. The innovation aims to improve the manufacturing processes and efficacy of pharmaceutical and nutraceutical products.

Career Highlights

Stefan Lander is currently employed at Omya International AG, a company known for its expertise in mineral-based solutions. His role involves research and development, where he applies his knowledge to create innovative excipients that meet industry standards.

Collaborations

Stefan collaborates with talented professionals, including Laura De Miguel and Lalit Sharma. Their combined expertise contributes to the advancement of their projects and the overall success of their innovations.

Conclusion

Stefan Lander's work exemplifies the importance of innovation in the pharmaceutical and nutraceutical industries. His contributions through patents and collaborations continue to pave the way for advancements in these fields.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…